Industry and Technology Division Council

Jacquin Wilford-Brown is currently the Analytical & Information Services Manager for International Paints, Felling, part of the Akzo Nobel group, making high performance products for the marine, yacht and protective coatings markets across the world. After leaving Cambridge with a PhD in organic electrochemistry, her industrial life started in colloids with ICI, but dispersed into materials and coatings (ICI and later Huntsman).  Much of that time was spent making new or improved products for applications ranging from bathrooms to shoes, usually sticking things together (but occasionally the reverse).  She has enjoyed the challenges of working in Europe (Belgium) and in Japan as well as the UK.  She moved into managing analytical about 10 years ago. 
In addition to her role on the Industrial and Technology Division Council, she also sits on the Innovation Strategy Board for Chemistry Innovation. This is very beneficial in sharing information and cementing the close relations between the two groups, which have many shared interests.

---

David Sadler is a chemist by training.  Following degrees from Durham and Southampton University he was granted a Royal Society fellowship to work at the Max Planck Insitut fuer Strahlenchemie in Germany.  He then joined ICI.  In a varied career he has worked as a research chemist in the ICI New Science Group, Runcorn, as a process physical chemist in the ICI Grangemouth manufacturing site, in R & D and marketing for the ICI speciality business in Blackley, Manchester.  When ICI demerged David stayed with Zeneca and moved to be R & D Director for Zeneca Speciality Inks in the USA before joining Zeneca Agrochemicals in Jealott's Hill in the South-East of England.  Today he is Head of Formulation Europe for Syngenta, the worlds leading Agibusiness, formed from a merger of the Zeneca and Novartis agriscience businesses in November 2000.  He manages staff in the UK and Switzerland and spends rather too much time on planes.  

---

---

---

Melissa Hanna-Brown is employed at Pfizer Global R+D Labs in Sandwich as a Lead Separation Scientist for a New Technology Group in Development Science and Technology. She is also a visiting Senior Lecturer in the Department of Pharmacy at King’s College London where she was previously employed as a Lecturer in Separation Sciences. Her PhD studies were carried out between King’s College London and SmithKline Beecham on prediction of drug-biomembrane partitioning. Her postdoctoral research involved developing novel triple-column electrophoretic technology allowing sensitive detection of trace components in complex matrices via 2D-CE. Her interests now include analytical technology development, high resolution strategies for complex biofluid profiling (or metabolomics) and predictive modelling of separations.

---

Allan Malcolm has over 30 years in the chemical industry mainly in a technical sales and business development role. Allan has worked for several different organisations both large and SMEs, in the contract manufacturing sector except for a brief 4 year period in the 2000's when I was employed as a Business Manger for Brenntag in the pharma sector. Allan is currently working with Peptisyntha, part of Solvay, as Business development and Sales Manager with responsibility for the ROW. Peptisyntha are involved in the contract manufacture of Peptide API's and Peptiomentics.
In addition Allan has been very active in the RSC since joining in the mid 80's. He is currently involved with two interest groups associated with the Industry and Technology Division. Allan is the Honorary Treasurer of the Management Group and an active member of the Marketing Group.  

---

Richard has 22 years of experience in both the chemical and the pharmaceutical sector, with a variety of both small and large companies and also within academia. He has worked in a variety of roles involving pre-formulation, formulation and latterly, intellectual property and business development. Richard originally trained in chemistry, with a PhD in synthetic organic chemistry from Loughborough University, followed by commercial post-doctoral work in pharmaceutical science. Richard also has a graduate diploma in law and a LLM in corporate law. He is currently a university Enterprise Business Manager for health, involved in the commercialisation of medical technology and has acted as a consultant for a number of companies. He is also the publicity chair for the society's interest group in law.

---

I joined the Wrigley in October 2009. Prior to that I worked for various commercial and government agencies in the UK and Ireland and spent one year working in the European Commission in Europe. My job titles have included Research Scientist, Contract Manager, Science Director, Associate Director Innovation, Director Scientific and Regulatory Affairs and Assistant Director Food. I have a degree in chemistry and a PhD in biological chemistry. I am a Fellow of The Royal Society of Chemistry, the Institute of Food Science and Technology and the Royal Society of Medicine. I am also a Chartered Chemist.

My research interests include biomarkers, oral health, natural product chemistry and biosynthesis, analytical methods and chemistry/biology interactions.

---

I received my first degree and PhD at Southampton with Phil Parsons. I then carried out post-doctoral work at Cornell (John McMurry) and Bath (Tim Gallagher) universities, before taking my first job in agro chemical discovery at Shell research at Sittingbourne .After a short spell in fine chemicals manufacturing in the NW, I joined SmithKline Beecham at Tonbridge working in chemical development. In 1998 I moved to Astra, which shortly became AstraZeneca, as director of Process Chemistry. 

---

Riaz joined AkzoNobel (formerly ICI) in 1987 as a corrosion scientist. Over a period of time Riaz acquired Polymer Science experience especially in extrusion processing. Riaz originally followed a Science Career path until1997 when he joined the Packaging Coatings Technical Management team. After guiding the development and commercialization of several Technologies Riaz return to pursue a Science career with AkzoNobel's Applied Research function in 2007. Riaz is currently working on several long range research projects for various AkzoNobel's Business Units.

---

---

---

Christian obtained his Masters of Chemistry Degree (Hons) from the University of Leeds, UK. His pharmaceutical experience started at GlaxoSmithKline where he worked for his Industrial Year Placement in the Process Chemistry Labs in Dartford, UK. Since then he has worked in a variety of roles both technical and commercial through small, medium and large Pharma. Post graduation he joined Tripos Discovery Research where he first worked in Process Chemistry before moving into the commercial side of the company in Marketing and Business Development. Christian's next move took him to Prosonix in Oxford, UK. (Biotech company which focusses in proprietary sonocrystallization, particle engineering and respiratory pharmaceutical development.) He was the first employee and was proactively involved in technology commercialisation and development. At Prosonix he managed global business development and marketing activities and assisted in growing the business to what it is today. In 2011 he joined Dr Reddy's based in Cambridge, UK where he currently works and is responsible for Business Development in Contract Research and Manufacture within Europe. 

---

---

David Evans obtained his BSc (1964) and MSc (1965) in chemistry from the University of Mancester, UK.  He completed his Ph.D in plant natural products there in 1967.  He held fellowships at MIT, Massachesetts, USA and at Cambridge University, UK, before appointment in 1971 as lecturer in Organic Chemistry at the University of Southampton, UK.  He was appointed in 1979 as Head of Chemistry, Fisions Agrochemical Division, UK and subsequently became Director of Research and a member of the Board of Schering Agrochemicals Ltd.  He joined ICI Agrochemicals in 1989 as Research General Manager and after demerger in 1993  he became Director of Research and Development of Zeneca Agrochemicals (later AstraZeneca). Following merger with Novartis 2000, he was appointed head of Research & Technology and member of the Executive Committee of Syngenta International AG, based in Basel, Switzerland.  Since his retirement in 2003, in addition to consultancy work, he has held several honorary positions including visiting professorships, board membership of a number of research institutes and membership of several scientific advisory boards.  He is involved with learned societies, including the RSC, SCI and IUPAC. 

---

Dr Michael Pitts, is an organic chemist by training (BSc, University of Loughborough and PhD, University of Exeter with Chris Moody). He worked as a postdoctoral associate at the University of Vienna on anti-tumour compounds as part of a collaborative European project before spending five years working in the chemical industry. Mike worked for catalyst technology SMEs StylaCats and Reaxa developing platforms in microwave technology, flow chemistry, homogeneous catalysis and process development. He joined Chemistry Innovation in 2007 and led the development of Chemistry Innovation’s Sustainable Design Guide and has used it to assist companies in developing more sustainable products. He has developed and managed projects on lifecycle analysis, renewable chemicals, industrial biotechnology and resource efficiency across the chemistry-using industries. Mike is currently Sustainability Manager managing projects and opportunities across all of Chemistry Innovation’s priority areas. He is also a trustee at Catalyst Science Discovery Centre. 

In this section

• Division Council
• Industry and Technology Interest Groups
• Industry knowledge centre
• Forthcoming Events

Tools